First, Cline et al. demonstrated that transmembrane glucose transport is the rate-controlling step in insulin-stimulated muscle glycogen synthesis in patients with type 2 diabetes mellitus [55]. This evidence concerns the gene INS and type 2 diabetes mellitus.